# Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine

> **NCT00994916** · — · NO_LONGER_AVAILABLE · sponsor: **David Lacomis, MD**

## Conditions studied

- Lambert-Eaton Myasthenic Syndrome

## Interventions

- **DRUG:** 3,4 diaminopyridine

## Key facts

- **NCT ID:** NCT00994916
- **Lead sponsor:** David Lacomis, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2019-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00994916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00994916, "Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00994916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*